$SERA

Jackson Benjamin sold $4K of SERA

Jackson Benjamin (General Counsel) sold 2,179 shares of SERA PROGNOSTICS, INC. (SERA) at $2.01 on 2026-06-11.

Original reporting
SEC EDGAR · Jackson Benjamin
Published Jun 15, 2026, 8:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SERA
Neutral
low confidence
Mentioned
$SERA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SERANeutralLow
01

Why it matters

The newest fact is the specific insider sale (2,179 shares at $2.0100) by the General Counsel, which can influence short-term sentiment but does not provide new business performance information.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a major repricing.

03

What to watch

Check whether there are additional insider transactions around the same period and whether the company has concurrent news (financing, trial updates, contracts) not present in this filing.

Relevance 3/10Novelty 5/10Timing: filed 2026-06-15 (transaction dated 2026-06-11)

Background

The article is an SEC Form 4 insider transaction disclosure sourced from EDGAR for SERA Prognostics, Inc.

Company-level read

Ticker impact

$SERANeutralLow confidence
Context

SEC Form 4 shows SERA’s General Counsel Jackson Benjamin sold 2,179 shares in an open-market transaction on 2026-06-11.

Expected impact

Likely limited near-term impact; any effect should be small unless follow-on selling accelerates or coincides with other news.

Evidence & confidence

The filing is a routine insider-sale disclosure with no 10b5-1 plan and no accompanying company-specific operational or financial update in the text.

Market effects

No sector read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

The sale may be for diversification or personal liquidity needs; without a 10b5-1 plan, it still doesn’t imply negative company fundamentals.

Key entities

  • SERA Prognostics, Inc.

    Company whose insider transaction is disclosed on Form 4.

  • Jackson Benjamin

    General Counsel reporting an open-market sale of SERA shares.

Related articles